CN Patent

CN106336363B — 一种沙芬酰胺甲磺酸盐晶型c及其制备方法

Assigned to Shanghai Pharmaceutical Group (Benxi) north pharmaceutical Co.,Ltd. · Expires 2018-10-30 · 8y expired

What this patent protects

本发明涉及沙芬酰胺甲磺酸盐的一种新晶型，命名为C型，以及其制备方法。本发明公开的沙芬酰胺甲磺酸盐晶型C其X‑射线粉末衍射图约在衍射角度2θ为8.503±0.1°，17.029±0.1°，20.087±0.1°，20.346±0.1°，21.965±0.1°，23.838±0.1°处具有特征峰。该晶型稳定好，制备方法简单，重复性好。

USPTO Abstract

本发明涉及沙芬酰胺甲磺酸盐的一种新晶型，命名为C型，以及其制备方法。本发明公开的沙芬酰胺甲磺酸盐晶型C其X‑射线粉末衍射图约在衍射角度2θ为8.503±0.1°，17.029±0.1°，20.087±0.1°，20.346±0.1°，21.965±0.1°，23.838±0.1°处具有特征峰。该晶型稳定好，制备方法简单，重复性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN106336363B
Jurisdiction
CN
Classification
—
Expires
2018-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceutical Group (Benxi) north pharmaceutical Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.